baber/WOPTO huggingface dataset:
Patent NO-953876-D0 (NO)
Inventor: VACCA JOSEPH P
IPC: A61K31/401
Filed: 1995-09-29
Abstract: Compounds of formula <CHEM> where R1 and R2 are independently hydrogen or optionally-substituted C1-4alkyl or aryl, or R1 and R2 are joined together to form a monocyclic or bicyclic ring system, are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Patent NO-972189-D0 (NO)
Inventor: PRUNBAUER KURT
IPC: E05B19/04
Filed: 1997-05-13
Abstract: The control surfaces (11) are formed via rib formations (10) on at least one of the key edges (5,6), the position of which within the key thickness determines the variations. The key has rib formations which are formed by a through, swung control rib on the key edges (5,6). Between the rib formations run inclined connecting sections (12) which are narrower than the rib formations. The rib formations are arranged on the key edges without connecting sections. The control rib or the first rib formation is arranged centrally on the key point (9). The first rib formation runs inclinedly in the direction of the key grip (3) opposite to the central longitudinal plane of the key.
Patent GB-0111279-D0 (GB)
Title: Radiolabelled liposomes
IPC: A61P43/00
Filed: 2001-05-10
Abstract: Liposomes of a specific bilayer composition containing an entrapped modifying compound are claimed. The liposomes of the invention are suitable for the internalisation of a variety of materials, even following long-term storage. Suitable materials of the invention include radiometals, parmagnetic compounds, radioopaque compounds and prodrugs. Upon internalisation, the material reacts chemically with the entrapped modifying compound such that said material remains internalised within the liposomes of the invention. Also claimed in the present invention are the liposomes containing internalised material and kits for their preparation. Furthermore, the use of said liposomes containing internalised material for the imaging infection, inflammation or tumour in a human is claimed.
Patent GB-0228960-D0 (GB)
Title: Improvements in or relating to processing systems
IPC: G06F19/00
Filed: 2002-12-11
Abstract: A processing system which comprises a processing apparatus and a processing agent which is administered to a processing subject. The processing agent has a primary behaviour which provides the desired process result in conjunction with the apparatus, but also has a distinctive signature characteristic which is detected by test functionality in the processing system. The behaviour of the processing system can be modified in response to the test result. In an example such as a contrast enhanced medical imaging, the full functionality of the imaging equipment may be available only if a contrast agent having the particular distinctive signature characteristic is used, thus tying use of the apparatus to use of a particular agent.
Patent GB-0305719-D0 (GB)
Title: Seal assembly
IPC: F16L7/02
Filed: 2003-03-13
Abstract: A seal assembly for dividing an annular space defined between an inner and an outer pipe in a double-walled pipeline, the seal assembly comprises an annular member 1 which fits in the annular space; and at least one longitudinal conveying means 6 passing through the annular member 1. The longitudinal conveying means 6 communicates with the annular space on either side of the seal assembly. The longitudinal conveying means may typically comprise electrical or heat conducting means or an optical fibre.
Patent GB-0402838-D0 (GB)
Title: Method
IPC: B29C35/02
Filed: 2004-02-10
Abstract: Provided is a method of producing a bioabsorbable, implantable substrate having a graded molecular weight distribution, comprising exposing at least a portion of the implantable substrate to electron beam irradiation. There is also provided a bioabsorbable, implantable substrate comprising a bioabsorbable polymer having a graded molecular weight distribution through at least a portion of its thickness.
Patent GB-0509419-D0 (GB)
Title: Measurement of binding rate of a binding substance and an analyte
IPC: G01N33/557
Filed: 2005-05-09
Abstract: A method of measuring the rate of binding of a binding substance and an analyte, for example in an assay such as an immunoassay, uses an initial step of performing ultrasonication sufficient to disrupt binding between the binding substance and the analyte. After cessation of the ultrasonication, measurements are taken to determine the rate of binding at cessation of said ultrasonication or at a predetermined time thereafter. The ultrasonication results in knowledge of the precise time of the start of the binding reaction which provides a better rate measurement.
Patent GB-0702392-D0 (GB)
Title: Apparatus and methods for automatic recognition, metering and energy output prediction of renewable energy devices
Filed: 2007-02-08
Abstract: A metering apparatus is used to meter at least one renewable energy device that derives energy from a renewable energy source such as a wind turbine 32 or combined heat and power (CHP) generator 34. The apparatus includes an electronic control unit 46 an energy sensor 44. The energy sensor 44 measures an energy parameter that is affected by an energy output of the renewable energy device. In the case of the embodiment shown in Figure 8 the energy sensor 44 is an electrical load sensor that measures electrical load flowing in the connection 42a between a supply busbar 36 and a distribution panel 42. The electrical load sensor provides energy data in the form of electrical load measurements to the electronic control unit 46. The electronic control unit 46 uses the energy data to derive a profile of the change in the energy parameter and correlates the derived profile with a reference profile corresponding to the particular type of renewable energy. The results of the correlation and the energy data are then used to quantify the energy output of the renewable energy device over a selected period of time.
Patent GB-0708363-D0 (GB)
Title: Mass spectrometer
Filed: 2007-04-30
Abstract: An ion guide or mass analyser is disclosed comprising a plurality of electrodes having apertures through which ions are transmitted in use. A pseudo-potential barrier is created at the exit of the ion guide or mass analyser. The amplitude or depth of the pseudo-potential barrier is inversely proportional to the mass to charge ratio of an ion. One or more transient DC voltages are applied to the electrodes of the ion guide or mass analyser in order to urge ions along the length of the ion guides or mass analyser. The amplitude of the transient DC voltage applied to the electrode may be increased with time so that ions are caused to be emitted from the ion guide or mass analyser in reverse order of their mass to charge ratio.
Patent GB-0800434-D0 (GB)
Title: A continuous track tensioning system
Filed: 2008-01-11
Abstract: This invention provides a continuous track tensioning system for tracked vehicles which are able to travel on a surface. The system comprises at least two tensioner means 180,182,190,192 each for applying a force to a track 110 to induce tension therein, wherein if the force applied by at least one of the tensioner means 180,182 is overcome by a force external to the system the tension in the track is maintained by the other at least one tensioner means 190,192. Hydraulic or pneumatic interlinking and a safety valve may be provided. The invention may comprise at least one tensioning means 190, 192 which applies a force generally downwards and may be allowed to pivot to a limited extent. The tensioning provided by the system improves efficiency and life and the system maintains tension even with unexpected external conditions.
Patent GB-0906760-D0 (GB)
Title: Methods and systems for investigating subterranean formations
Filed: 2009-04-20
Abstract: An EM-seismic logging tool for use in a subterranean formation penetrated by a well bore is configured to make electromagnetic and seismic measurements simultaneously using an EM receiver array for both measurements. The electromagnetic receivers R measure an electromagnetic field and perturbations in the electromagnetic field caused by the mechanical energy generated by the activation of a seismic source 10. The perturbations in the measured electromagnetic field are due to motion of the receiver or motion of the formation. The electromagnetic field may be generated by a transmitter T or may be the earth's naturally occurring electromagnetic field. The transmitter T may be in the wellbore, in a second wellbore, or on the surface. The seismic source may be in the wellbore or on the surface. The receivers R may be clamped to the formation or mechanically isolated from the wellbore walls using soft centralizers. The EM transmitter, EM receivers and seismic source may be synchronised through GPS.
Patent GB-8515263-D0 (GB)
Title: Cyclone separator
IPC: B04C/
Filed: 1985-06-17
Abstract: PCT No. PCT/AU86/00174 Sec. 371 Date Mar. 2, 1987 Sec. 102(e) Date Mar. 2, 1987 PCT Filed Jun. 17, 1986 PCT Pub. No. WO86/07549 PCT Pub. Date Dec. 31, 1986.This invention is about a cyclone separator, and may be applied to the cyclone separators disclosed and claimed in UK Pat. Nos. 1583742, 1583730 or 2102311, or those described in UK Patent Application 8419771 or 8511149 or 8515264. Thus, application 8419771 describes a cyclone separator which has an inlet portion having generally the form of a volume of revolution with a single tangential inlet (preferably with an involute feed channel, for introducing feed to be separated into the cyclone separator and, adjacent to the inlet portion and substantially coaxial therewith, a generally axially symmetrical separation portion converging uninterruptedly into a downstream portion. The inlet portion has an axial overflow outlet opposite the separation portion (i.e. in its end wall). The involute feed channell may be fed from a duct directed tangentially into the inlet portion, the (outer) wall of the channel converging to the principal diameter of the inlet portion, preferably by substantially equal radial decrements per unit angle around the axis, preferably attaining the principal diameter after 360 DEG around the axis.
Patent GB-8623803-D0 (GB)
Title: Quality control device
IPC: G01N21/93
Filed: 1986-10-03
Abstract: Wire processing apparatus employs a conveyor for transporting wire segments to a series of wire processing machines which strip insulation from the wire segment ends and then subsequently attach electric terminals to the stripped ends. A quality control device located between the insulation stripper machine and the terminal attachment machine inspects each stripped end and, if it does not meet desired tolerances, sends signals which prevent the terminal attachment machine from operating upon the defective stripped end as the conveyor moves the wire segment therepast. The quality control device comprises an illuminated field at which the stripped end momentarily stops, an optical lens opposite the illuminated field for providing an optical image of the stripped end, and a converter for converting the optical image to an electronic image signal. Solid state electronic circuits compare the image signal to a reference signal, provide an error signal if the stripped end is defective and store the error signal in a memory circuit. The error signal, if present, is recalled from the memory at the appropriate time and converted to an output signal which prevents the downstream terminal attachment machine from operating on the defective wire end.
Patent GB-8708805-D0 (GB)
Title: Garment
IPC: A41B9/04
Filed: 1987-04-13
Abstract: A garment for shaping the lower human torso, comprises a front cloth 1, 2, 3, in which at least the areas excluding a central abdominal portion are stretchable, and a stretchable rear cloth 4, 5. The front cloth comprises at least three cloth pieces including a central front piece 1 and left-side 2 and right-side 3 front pieces extending symmetrically about said central front piece in a direction linking the groin with the iliac spine, said front side pieces being folded double at their hem edges, the main stretching direction of said front side pieces being parallel to said folded edges A-A, and there being a strip of elastic material sewn along the respective hem edges of the garment excluding the folded edges of said front side pieces. <IMAGE>
Patent GB-8920011-D0 (GB)
Title: New route of synthesis for tertiary butyl esters
IPC: C07C231/12
Filed: 1989-09-05
Abstract: PCT No. PCT/GB90/01371 Sec. 371 Date Apr. 10, 1992 Sec. 102(e) Date Apr. 10, 1992 PCT Filed Sep. 5, 1990 PCT Pub. No. WO91/03460 PCT Pub. Date Mar. 21, 1991.4-[(2-chloroethyl)-(2-hydroxyethyl)-amino]benzoyl amino acids of formula (IV), wherein X represents a group (a), where Pro represents hydrogen or a straight or branched chain C1-6 alkyl group, and salts thereof, and processes for their production. The compounds are useful for the production of nitrogen mustard prodrugs    <IMAGE>  (IV)   <IMAGE>  (a)
Patent GB-8928848-D0 (GB)
Title: Roll surface cutting method
IPC: H01B1/02
Filed: 1989-12-21
Abstract: A bonding wire (3) for connecting an electrode of a semiconductor element to an external lead (2), which comprises 1 to less than 5 wt % of copper and the balance of gold and unavoidable impurities, and which has excellent break strength and bonding strength to provide reliable connection even in a thickness as small as about 10  mu m in diameter.
Patent GB-9022011-D0 (GB)
Title: Chimaeric antibodies and their preparation
IPC: C12Q1/686
Filed: 1990-10-10
Abstract: PCT No. PCT/GB91/01744 Sec. 371 Date Jul. 29, 1993 Sec. 102(e) Date Jul. 29, 1993 PCT Filed Oct. 8, 1990 PCT Pub. No. WO92/07075 PCT Pub. Date Apr. 30, 1992The invention relates to a method of producing a chimaeric antibody in which the CDR of a first antibody is spliced between the framework regions of a second antibody. The method is performed using a template comprising two framework regions, AB and CD, and between them, the CDR which is to be replaced by a donor CDR. Primers A and B are used to amplify the framework region AB, and primers C and D used to amplify the framework region CD. However, the primers B and C also contain, at their 5' ends, additional sequence corresponding to all or at least part of the donor CDR sequence. Primers B and C overlap by a length sufficient to permit annealing of their 5' ends to each other under conditions which allow a polymerase chain reaction to be performed and thereby incorporate all of the donor CDR sequence. The amplified regions AB and CD may undergo splice overlap extension to produce the chimaeric product in a single reaction.
Patent GB-9101560-D0 (GB)
Title: Fluid delivery system
IPC: A61M16/18
Filed: 1991-01-24
Abstract: PCT No. PCT/GB92/00140 Sec. 371 Date Jul. 23, 1993 Sec. 102(e) Date Jul. 23, 1993 PCT Filed Jan. 24, 1992 PCT Pub. No. WO92/12753 PCT Pub. Date Aug. 6, 1992.A system for delivery of volatile liquid drugs as supplied to a patient by an anaesthetic vaporizer comprises a supply container (2) and a vaporizer (32) which includes a sump. Each of the supply container and the vaporizer is provided with a valve assembly (6, 34) which, when closed, prevent passage of fluid from the supply container into the sump. The supply container and the sump are connected to one another by means of a bayonet connection, which is made when indexing elements on the containers correspond. The valve assemblies in the containers are opened when the containers are connected to one another by means of an insert (40) located within an inlet conduit (10) linking the two containers. The inlet conduit (10) is rotatable between lowered and raised positions, to open a valve (37) by which flow of fluid into and out of a reservoir for fluid in the sump can be controlled.
Patent GB-9226453-D0 (GB)
Title: Metal oxide catalyst
IPC: C01B32/50
Filed: 1992-12-18
Abstract: A catalyst composed of metal oxide particles among which are uniformly incorporated, in order to reduce the operating temperature of the catalyst, palladium particles.
Patent GB-9423030-D0 (GB)
Title: An illuminated awning
IPC: E04F10/02
Filed: 1993-05-18
Abstract: PCT No. PCT/IE93/00028 Sec. 371 Date Nov. 9, 1994 Sec. 102(e) Date Nov. 9, 1994 PCT Filed May 18, 1993 PCT Pub. No. WO93/23634 PCT Pub. Date Nov. 25, 1993An awning comprises an outer sheet of flexible material supported on a rigid translucent support. The awning is illuminated by strip lights mounted on a support framework, which is stepped back from the rigid translucent support. An even illumination is achieved with no shadow lines on the flexible sheet. The sheet may have advertising indicia or logos.
Patent GB-9610317-D0 (GB)
Title: Vial autosampler
IPC: G01N21/35
Filed: 1996-05-17
Abstract: Apparatus for spectrophotometric analysis of material in vials 16 in which material in each vial is subjected to a beam 4 at a scanning station 20. An array of the vials 16 is carried by a carousel 60 for each vial 16 automatically and sequentially to be delivered to the scanning station and thereafter removed following scanning by the beam 4. Rotation of the carousel 60 to feed the vials to the scanning station and to remove them from that station is controlled by a computer 3 which also controls spectrophotometric measurement of the material in the respective vials whilst at the scanning station. <IMAGE>
Patent GB-9710905-D0 (GB)
Title: Stent for blood vessel
IPC: A61F2/82
Filed: 1997-05-27
Abstract: A stent for supporting part of a blood vessel which stent includes a supporting portion around which or within which part of a blood vessel intended for grafting can be placed so that the stent internally or externally supports that part and the supporting portion of the stent is of a shape and/or orientation whereby flow between graft and host vessel is caused to follow a non-planar curve. By maintaining non-planar curvature in the graft itself, favorable blood flow velocity patterns can be achieved through generation therein of "swirl' flow. Failures in such grafts through blockage, kinking or collapse, can be significantly reduced.
Patent GB-9717006-D0 (GB)
Title: Radio selective calling receiver using time diversity reception
IPC: H04B7/26
Filed: 1997-08-11
Abstract: A radio selective calling receiver includes a field strength detection unit for detecting a received field strength, a first time diversity processing section for performing time diversity processing with a large time diversity effect and large power consumption, a second time diversity processing section for performing time diversity processing with a small time diversity effect and small power consumption, and a selection unit for determining, on the basis of a detection result from the field strength detection unit, whether the received field strength is high or low, and selecting the first time diversity processing section for a low field strength or the second time diversity processing section for a high field strength.
Patent GB-9805883-D0 (GB)
Title: Hydraulic control means
IPC: F15B13/042
Filed: 1998-03-20
Abstract: The disclosure relates to a hydraulic remote control (HRC) valve including a main spool valve (1) and a pilot pressure control valve (2). A lever (11) is operatively connected to the pilot valve (2) whereby to provide "finger tip" control of the main spool valve (1). The HRC has an inverting output, whereby movement of the lever (11) away from a neutral position causes a decrease in hydraulic pressure supplied to a hydraulic clutch. In practice, two HRC's according to the invention are embodied in a single housing (20). The HRC of the invention is of use in controlling the hydraulic steering clutches of tracked vehicles. <IMAGE>
Patent GB-9908348-D0 (GB)
Title: Apparatus for controlling gas temperature in compressors
IPC: F04B39/06
Filed: 1997-10-14
Abstract: An apparatus is provided for controlling gas temperature during compression or expansion. The apparatus comprises a chamber for containing gas, a piston for changing the volume of gas in the chamber, a plurality of atomisers for spraying liquid into the chamber and means for delivering liquid to the atomisers. Each atomiser comprises a spray aperture and means defining a flow path for imparting rotary motion to the flow of liquid about the axis of the aperture so that on leaving the aperture the liquid divides into a conical spray. Spray apertures are positioned adjacent one another and the axes of adjacent spray apertures are oriented such that their respective sprays intersect at a position proximate at least one of the respective adjacent spray apertures.
Patent HU-0304096-D0 (HU)
Title: Process for the production of pioglitazone hydrogenchloride
IPC: C07D213/30
Filed: 2003-12-19
Abstract: The invention relates to a process for the synthesis of pioglitazone hydrogen chloride - which is an antidiabetic drug - via novel intermediates by reacting 4-[2-(5-ethyl-2-pyridinyl)-ethoxy]-benzaldehyde salt of formula (II), wherein HX is: HCI, CF3COOH, C4H4O4, (COOH)2 with a base and then thiazolidine-2,4-dione, and the obtained 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-2,4-thiazolidinedione base is treated with hydrochloric acid and the obtained 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methylene]-2,4-tiazolidinedione hydrogen chloride of formula(III) is hydrogenated in the presence of a catalyst. Further objects of the invention are the salts of general formula (II) and the benzylidene derivative of formula (III).
Patent HU-9402077-D0 (HU)
Title: Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptrable salts of gamma hydroxy-butyric acid
Inventor: CONTE UBALDO
IPC: A61K9/22
Filed: 1994-07-12
Abstract: Controlled release pharmaceutical compositions administrable by oral route, containing as the active principle at least one salt of the gamma hydroxy butyric acid with a pharmaceutically acceptable cation, for the treatment of alcoholism, opium like substances addiction, heroin addiction, food and nicotine addiction, depressive and anxious states, composed by:   a) a nucleus in the form of granules and tablets comprising an active principle dispersed in a particular cellulosic matrix;  and optionally by: b) a filming protection of the nucleus. e